Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates

分组1 - Zoetis reported quarterly earnings of $1.76 per share, exceeding the Zacks Consensus Estimate of $1.62 per share, and showing an increase from $1.56 per share a year ago, resulting in an earnings surprise of +8.64% [1] - The company achieved revenues of $2.46 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.44%, and up from $2.36 billion in the same quarter last year [2] - Over the last four quarters, Zoetis has consistently surpassed consensus EPS and revenue estimates [2] 分组2 - The stock has underperformed, losing about 6.8% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $1.67 for the coming quarter and $6.26 for the current fiscal year [7] - The Zacks Industry Rank places Medical - Drugs in the top 37% of over 250 Zacks industries, indicating a favorable industry outlook [8]